UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of Age and Age of Onset on Prescribed Antipsychotic Dose in Schizophrenia Spectrum Disorders: A Survey of 1,418 Patients in Japan

The American journal of geriatric psychiatry, 2008-07, Vol.16 (7), p.584-593

2008

Volltextzugriff (PDF)

Effectiveness of herbal medicine (Rokumigan and Hachimijiogan) for fatigue or loss of energy in patients with partial remitted major depressive disorder

Psychiatry and clinical neurosciences, 2005-10, Vol.59 (5), p.610-612

2005

Volltextzugriff (PDF)

Factor structure of the targeted inventory on problems in schizophrenia

Clinical Psychopharmacology and Neuroscience, 2013, 11(1), , pp.18-23

2013

Volltextzugriff (PDF)

Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: A randomized controlled trial

Psychiatry and clinical neurosciences, 2003-04, Vol.57 (2), p.183-187

2003

Volltextzugriff (PDF)

Discrepancies Between Nomenclature and Indications of Psychotropics

Pharmacopsychiatry, 2019-07, Vol.52 (4), p.175-179

2019

Volltextzugriff (PDF)

Association between dopamine D4 receptor (D4DR) Exon III polymorphism and novelty seeking in Japanese subjects

American journal of medical genetics, 1997-09, Vol.74 (5), p.501-503

1997

Volltextzugriff (PDF)

Antipsychotic-induced hyperprolactinemia inhibits the hypothalamo-pituitary-gonadal axis and reduces bone mineral density in male patients with schizophrenia

The journal of clinical psychiatry, 2008-03, Vol.69 (3), p.385-391

2008

Volltextzugriff (PDF)

A survey on the drug therapy for delirium

Psychiatry and clinical neurosciences, 2001-08, Vol.55 (4), p.397-401

2001

Volltextzugriff (PDF)

Effectiveness of Gorei-san (TJ-17) for treatment of SSRI-induced nausea and dyspepsia: Preliminary observations

Clinical neuropharmacology, 2003-05, Vol.26 (3), p.112-114

2003

Volltextzugriff (PDF)

Mood stabilizers as an Achilles’ heel for indication‐based nomenclature and roles of Neuroscience‐based Nomenclature

Psychiatry and clinical neurosciences, 2018-12, Vol.72 (12), p.854-855

2018

Volltextzugriff (PDF)

Association between a polymorphism in the promoter region of the dopamine D2 receptor gene and schizophrenia in Japanese subjects: replication and evaluation for antipsychotic-related features

The international journal of neuropsychopharmacology, 1999-09, Vol.2 (3), p.181-186, Article S1461145799001492

1999

Volltextzugriff (PDF)

Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders

Journal of affective disorders, 1996-09, Vol.40 (1), p.7-13

1996

Volltextzugriff (PDF)

Elevated plasma nitrate levels in depressive states

Journal of affective disorders, 2001-03, Vol.63 (1), p.221-224

2001

Volltextzugriff (PDF)

Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia

Human psychopharmacology, 2009-12, Vol.24 (8), p.628-638

2009

Volltextzugriff (PDF)

A Proposal for Natural Resilience Theory in Psychopharmacotherapy: To Deter High-dose Antipsychotic Polypharmacy

Psychiatria et neurologia Japonica, 2015, Vol.117 (1), p.10

2015

Volltextzugriff (PDF)

Current topics in tardive dyskinesia in Japan

Psychiatry and clinical neurosciences, 1995-12, Vol.49 (5‐6), p.239-244

1995

Volltextzugriff (PDF)

How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone? : A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting

Psychopharmacologia, 2007-12, Vol.195 (2), p.285-295

2007

Volltextzugriff (PDF)

Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open-label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidone

Human psychopharmacology, 2008-08, Vol.23 (6), p.455-463

2008

Volltextzugriff (PDF)

Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol

Schizophrenia research, 2002-10, Vol.57 (2), p.227-238

2002

Volltextzugriff (PDF)

Benzodiazepine and antidepressant use in elderly patients with anxiety disorders: A survey of 796 outpatients in Japan

Journal of anxiety disorders, 2009-05, Vol.23 (4), p.477-481

2009

Volltextzugriff (PDF)

Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study

Psychiatry research, 2006-01, Vol.141 (1), p.61-69

2006

Volltextzugriff (PDF)

Educational system for training doctors engaged in clinical trials

International clinical psychopharmacology, 2001-09, Vol.16 (5), p.301

Yagi, Gohei

2001

Volltextzugriff (PDF)

Novel rating scales for schizophrenia — Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz)

Schizophrenia research, 2008-12, Vol.106 (2), p.328-336

2008

Volltextzugriff (PDF)

Magnitude of rater differences in assessment scales for schizophrenia

Journal of clinical psychopharmacology, 2010-10, Vol.30 (5), p.607-611

2010

Volltextzugriff (PDF)

Environmental and Possible Genetic Contributions to Character Dimensions of Personality

Psychological reports, 1999-04, Vol.84 (2), p.689-696

1999

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(115)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(64)
Life Sciences & Biomedicine
(63)
Science & Technology
(63)
Psychiatry
(53)
Adult
(48)
Male
(48)
Female
(47)
Middle Aged
(47)
Biological And Medical Sciences
(38)
Neurosciences & Neurology
(37)
Medical Sciences
(34)
Neurosciences
(31)
Schizophrenia
(30)
Psychology. Psychoanalysis. Psychiatry
(29)
Schizophrenia - Drug Therapy
(28)
Pharmacology & Pharmacy
(27)
Aged
(26)
Clinical Neurology
(24)
Pharmacology. Drug Treatments
(22)
Antipsychotic Agents - Adverse Effects
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of Age and Age of Onset on Prescribed Antipsychotic Dose in Schizophrenia Spectrum Disorders: A Survey of 1,418 Patients in Japan

Effectiveness of herbal medicine (Rokumigan and Hachimijiogan) for fatigue or loss of energy in patients with partial remitted major depressive disorder

Factor structure of the targeted inventory on problems in schizophrenia

Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: A randomized controlled trial

Discrepancies Between Nomenclature and Indications of Psychotropics

Association between dopamine D4 receptor (D4DR) Exon III polymorphism and novelty seeking in Japanese subjects

Antipsychotic-induced hyperprolactinemia inhibits the hypothalamo-pituitary-gonadal axis and reduces bone mineral density in male patients with schizophrenia

A survey on the drug therapy for delirium

Effectiveness of Gorei-san (TJ-17) for treatment of SSRI-induced nausea and dyspepsia: Preliminary observations

Mood stabilizers as an Achilles’ heel for indication‐based nomenclature and roles of Neuroscience‐based Nomenclature

Association between a polymorphism in the promoter region of the dopamine D2 receptor gene and schizophrenia in Japanese subjects: replication and evaluation for antipsychotic-related features

Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders

Elevated plasma nitrate levels in depressive states

Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia

A Proposal for Natural Resilience Theory in Psychopharmacotherapy: To Deter High-dose Antipsychotic Polypharmacy

Current topics in tardive dyskinesia in Japan

How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone? : A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting

Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open-label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidone

Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol

Benzodiazepine and antidepressant use in elderly patients with anxiety disorders: A survey of 796 outpatients in Japan

Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study

Educational system for training doctors engaged in clinical trials

Novel rating scales for schizophrenia — Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz)

Magnitude of rater differences in assessment scales for schizophrenia

Environmental and Possible Genetic Contributions to Character Dimensions of Personality

Suchergebnisse filtern